Ligand validation:7XYL

I55: [(2~{R},3~{R},4~{S},5~{R},6~{R})-6-[(~{E})-[(3~{a}~{S},7~{R},7~{a}~{S})-7-oxidanyl-4-oxidanylidene-3,3~{a},5,6,7,7~{a}-hexahydro-1~{H}-imidazo[4,5-c]pyridin-2-ylidene]amino]-5-(2-azanylethanoylamino)-2-(hydroxymethyl)-4-oxidanyl-oxan-3-yl] carbamate

I55 is a Ligand Of Interest in 7XYL designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7XYL_I55_E_1140	64%	41%	0.133	0.933	1.1	1.21	1	2	0	0	100%	1
7XYL_I55_B_1164	60%	43%	0.132	0.917	1.02	1.19	1	3	0	0	100%	1
7XYL_I55_A_1147	58%	36%	0.148	0.928	1.03	1.49	1	2	0	0	100%	1
7XYL_I55_C_1153	57%	48%	0.135	0.91	0.82	1.18	1	2	0	0	100%	1
7XYL_I55_F_1181	53%	44%	0.153	0.913	1	1.15	1	2	0	0	100%	1
7XYL_I55_G_1156	51%	50%	0.156	0.911	0.8	1.13	1	2	0	0	100%	1
7XYL_I55_D_1023	48%	54%	0.16	0.901	0.79	1	1	1	0	0	100%	1
7XYL_I55_H_1037	44%	56%	0.17	0.898	0.74	0.96	1	2	0	0	100%	1
7XXC_I55_E_702	76%	41%	0.113	0.948	1.13	1.17	2	1	0	0	100%	1
8GRI_I55_A_703	74%	5%	0.134	0.964	2.96	2.43	1	6	0	0	100%	1
7XX0_I55_E_702	63%	45%	0.138	0.933	1	1.12	1	2	0	0	100%	1
7XXR_I55_G_702	61%	52%	0.158	0.948	0.67	1.16	-	3	0	0	100%	1
7Y0X_I55_C_702	56%	49%	0.14	0.91	0.96	0.99	1	2	0	0	100%	1
7YPU_I55_E_201	65%	57%	0.137	0.939	0.59	1.06	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.